Medicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab

THURSDAY, May 18, 2023 -- If eligible patients received lecanemab, Medicare would spend an extra $2.0 to $5.1 billion annually, according to a research letter published online May 11 in JAMA Internal Medicine to coincide with the annual meeting of...